You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Mike Raab

President & Chief Executive Officer at Ardelyx, Inc.
Overview
Relationships
In The News
Paths
Education
Career History
Boards & Committees
Non-Profit Donations & Grants
Political Donations
Investments
Public Holdings
Transactions

Mike Raab

President & Chief Executive Officer at Ardelyx, Inc.

Overview

Age
53 (Born 1965)
Notable Companies
Ardelyx, Inc.
Board Seats
14
Number of Relationships
This person is connected to 1,363 people.

Relationships See Details


General Partner & Head, Healthcare Investing Practice at New Enterprise Associates LLC

Partner at Latham & Watkins LLP

President at Sofinnova Ventures, Inc.

Former Chairman, President & Chief Executive Officer at OncoMed Pharmaceuticals, Inc.

Chief Executive Officer at Amicus Therapeutics, Inc.

Former President & Chief Executive Officer at CymaBay Therapeutics, Inc.

Director/Member of the Exempt Reporting Adviser at NEA Management Co. LLC

Director, President & Chief Executive Officer, Amyris at Amyris, Inc.

Chief Executive Officer at PlaqueTec Ltd.

Former President & Chief Executive Officer at Codexis, Inc.
See 1,353 more listings with RelSci Professional.

In The News See More

PR Newswire
January 3, 2018
PR Newswire
December 11, 2017
PR Newswire
November 28, 2017
PR Newswire
November 21, 2017
FierceBiotech
November 21, 2017
See full news coverage and complete stories with RelSci Professional.

Paths to Mike Raab

Mike Raab
You
Connections via Relationship Science
Mike Raab
Sync your contacts to see how you can connect with Mike Raab.

Educational Background

B.A. 
DePauw University in Greencastle, Indiana, USA, is a private, national liberal arts college and School of Music with an enrollment of approximately 2,400 students. The school has a Methodist heritage and was originally known as Indiana Asbury University. DePauw is a member of both the Great Lakes Colleges Association and the North Coast Athletic Conference. The Society of Professional Journalists was founded at DePauw. DePauw is home to both the first modern-day sorority and the two longest continuously-running fraternities in the world.

Career History

President & Chief Executive Officer
2009 - Current
Ardelyx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of minimally-systemic, small molecule therapeutics that work exclusively in the gastrointestinal, tract to treat gastrointestinal and cardio-renal diseases. The company's products include Tenapanor, RDX002, RDX009 and RDX013. Ardelyx was founded by Dominique Charmot, Peter G. Schultz and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.
Partner
2002 - 2008
New Enterprise Associates (NEA) focuses on investments in the technology and healthcare sectors. The firm's investment strategy spans all stages of a company's growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders. NEA actively invests in emerging markets, with emphasis on India and China.NEA's investments in the healthcare sector focus on companies that address unmet or underserved clinical needs and that combine improved clinical outcomes with lower costs to the market. The firm targets three areas including biopharmaceuticals, medical devices and healthcare services. The firm has a history of partnering with companies that have pioneered transformative innovations in healthcare, such as balloon angioplasty and laparoscopic surgeryWithin the technology sector, NEA focuses on investments in the electronics, consumer technology, enterprise mobility, virtualization, tech-enabled services, SaaS and cloud computing industries.
Senior Vice President-Therapeutics & General Manager-Renagel
1994 - 2002
Genzyme Corp. develops and manufactures specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
Senior Vice President
Prior
Therapeutics, Inc. is a private company headquartered in Reston, VA. The firm develops therapies and biomarkers for bone diseases.
Sales & Marketing
Prior
Repligen Corp. engages on the development, production and commercialization of products used in the process of manufacturing biological drugs. It offers upstream solutions, downstream solutions, and analytics. The upstream solutions offers XCell ATF System and cell culture supplements. The downstream solutions includes OPUS pre-packaged chromatography columns; Protein A affinity resins; and Protein A Ligands. The analytics involves ELISA kits. The company was founded by Alexander G. Rich in May 1981 and is headquartered in Waltham, MA.
Sales & Marketing
Prior
Bristol-Myers Squibb Company Our company has a strong legacy of innovation that began in New York in 1858 when Edward R. Squibb, M.D., founded a pharmaceutical company in Brooklyn, and in 1887 when two friends, William McLaren Bristol and John Ripley Myers purchased a struggling drug manufacturing firm in Clinton. Together, they laid the foundation for our company today — a global BioPharma leader that continues this legacy of innovation.

Boards & Committees

Corporate Boards ▾
Member, Board of Directors
2009 - Current
Ardelyx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of minimally-systemic, small molecule therapeutics that work exclusively in the gastrointestinal, tract to treat gastrointestinal and cardio-renal diseases. The company's products include Tenapanor, RDX002, RDX009 and RDX013. Ardelyx was founded by Dominique Charmot, Peter G. Schultz and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.
Member, Board of Directors
2004 - Current
Amicus Therapeutics, Inc. is a biotechnology company, which is engaged in the discovery, development and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.
Director
Prior - 2009
Progen Pharmaceuticals, Inc. develops biopharmaceuticals products. It is engaged in developing improved drug delivery based on their transporter molecules. The company is headquartered in Redwood City, CA.
Director
2002 - 2009
Novacea, Inc. is a privately held biopharmaceutical company focused on licensing, developing and commercializing novel agents to revolutionize the treatment of cancer. Novacea’s in-licensed product portfolio features three clinical stage oncology therapeutics. The Company has two products which are anticipated to commence Phase 3 clinical trials in 2006, DN-101 and vinorelbine oral. Banoxantrone (AQ4N) is in Phase 1/2 clinical trials. It is located in South San Francisco, CA.
Director
2002 - Prior
Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases.
Director
Prior
Liquidia Technologies, Inc. designs, develops, and manufactures precisely engineered particles and films for applications in life and materials science sectors. It develops micro and nanoparticles for the delivery of biological and small molecule therapeutics, as well as for the development of vaccines and inhaled therapeutics in the life sciences sector. The firm also develops nano-patterned optical films for displays, lighting, photovoltaics, and related applications in the material science sector. The company was founded in 2004 and is headquartered in Durham, NC.
Director
Prior
Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA.
Director
Prior
ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA.
Director
Prior
Hyperion Therapeutics, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat disorders in orphan diseases and hepatology. Its product, Ravicti is designed to lower ammonia in blood and for the treatment of urea cycle disorders and hepatic encephalopathy. The company was founded by Mark Blumling and Chris E. Rivera on November 1, 2006 and is headquartered in Brisbane, CA.
Member-Life Sciences Advisory Board
Tenure Unconfirmed
Silicon Valley Bank is the California bank subsidiary and the commercial banking operation of SVB Financial Group. Banking services are provided by Silicon Valley Bank, a member of the FDIC and the Federal Reserve System. SVB Private Bank is a division of Silicon Valley Bank. SVB Financial Group is also a member of the Federal Reserve System.
Non-Profit Boards ▾
Member, Emerging Companies Section Governing Board
Current
Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
Director
Current
California Biomedical Innovation Alliance is an American private company located in South San Francisco, CA. The firm provides biomedical advocacy and community services. Sara Radcliffe is currently the CEO of the company. The firm's website shows the following as a description of the company: California Life Sciences Association (CLSA) is the state’s largest and most influential life sciences advocacy and business leadership organization. With offices in Sacramento, San Diego, South San Francisco, Los Angeles and Washington DC, CLSA works closely with industry, government, academia and others to shape public policy, improve access to innovative technologies and grow California’s life sciences economy. CLSA serves bio technology, pharmaceutical, medical de vice and diagnostics companies, research universities and institutes, investors and service providers throughout the Golden State. CLSA was founded in 2015 when the Bay Area Bioscience Association (BayBio) and the California Healthcare Institute (CHI) merged.
Member of the Healthcare Advisory Board
Current
Entrepreneurs Foundation provides privately held companies expert advice on corporate social responsibility and philanthropy. The company was founded in 1998 and is headquartered in Mountain View, CA.
Member
Prior
BayBio brings together the collective strength and experience of the world’s most innovative and productive life science cluster, helping companies grow, connect and advocate to solve some of humanity’s most pressing challenges. BayBio provides comprehensive support and solutions tailored to the unique needs of nearly 1000 Bay Area life science companies and institutions, delivering tangible value through group purchasing savings, capital access, government affairs & advocacy, networking and best-practice sharing. BayBio also supports the future of bioscience innovation through the BayBio Institute’s work in science education, career development and entrepreneurship.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2008
DePauw University in Greencastle, Indiana, USA, is a private, national liberal arts college and School of Music with an enrollment of approximately 2,400 students. The school has a Methodist heritage and was originally known as Indiana Asbury University. DePauw is a member of both the Great Lakes Colleges Association and the North Coast Athletic Conference. The Society of Professional Journalists was founded at DePauw. DePauw is home to both the first modern-day sorority and the two longest continuously-running fraternities in the world.

Political Donations

$250
2008
Former Senator from New York
$1,050
2008
Former President of United States
$500
2007
$500
2006
$500
2005
See 3 more listings with RelSci Professional.

Investments

Details Hidden
Ardelyx, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of minimally-systemic, small molecule therapeutics that work exclusively in the gastrointestinal, tract to treat gastrointestinal and cardio-renal diseases. The company's products include Tenapanor, RDX002, RDX009 and RDX013. Ardelyx was founded by Dominique Charmot, Peter G. Schultz and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.

Public Holdings

Restricted data only for RelSci Professional users.

Transactions

Details Hidden
Ardelyx, Inc. raised money in a private placement transaction
Details Hidden
Ardelyx, Inc. raised money in a private placement transaction
Details Hidden
Ardelyx, Inc. raised money in a private placement transaction
Details Hidden
Ardelyx, Inc. raised money in a private placement transaction

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.